| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | |
|---|---|---|---|---|---|---|
Revenues | ||||||
Revenues | ||||||
428,212 | 198,220 | 238,387 | 1,070 | 8,816 | 13,035 | |
Expenses | ||||||
Cost of sales - product | ||||||
71,190 | 28,705 | 4,974 | 0 | - | - | |
Research and development | ||||||
927,338 | 679,005 | 269,018 | 98,033 | 58,250 | 21,862 | |
Selling, general and administrative | ||||||
388,249 | 195,385 | 62,602 | 20,097 | 7,311 | 6,930 | |
Amortization of intangible assets | ||||||
1,326 | 894 | 250 | 0 | 0 | - | |
Total expenses | ||||||
1,388,103 | 903,989 | 336,844 | 118,130 | 65,561 | 28,792 | |
Loss from operations | ||||||
-959,891 | -705,769 | -98,457 | -117,060 | -56,745 | -15,757 | |
Interest income, net | ||||||
9,131 | 13,947 | -4,108 | 383 | 559 | -3,512 | |
Gains (Losses) from Decrease (Increase) in Fair Value of Financial Instruments | ||||||
- | - | - | -1,514 | -1,826 | -2,760 | |
Gain (loss) on sale of available-for-sale securities | ||||||
- | - | - | - | -314 | - | |
Gain on debt extinguishment | ||||||
- | - | - | - | - | 2,883 | |
Other income, net | ||||||
7,174 | 1,993 | 11,501 | -972 | 1,224 | 600 | |
Loss before income taxes | ||||||
-943,586 | -689,829 | -91,064 | -119,163 | -57,102 | -18,546 | |
Income tax expense | ||||||
6,992 | -15,796 | 2,235 | 54 | 0 | 0 | |
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | ||||||
-950,578 | -674,033 | -93,299 | -119,217 | -57,102 | -18,546 | |
Less: net loss attributable to noncontrolling interests | ||||||
-1,950 | -264 | -194 | 0 | - | -268 | |
Net loss attributable to BeiGene, Ltd. | ||||||
-948,628 | -673,769 | -93,105 | -119,217 | -57,102 | -18,278 | |
Net loss per share attributable to BeiGene, Ltd., basic and diluted (in dollars per share) | ||||||
-1.22 | -0.93 | -0.17 | -0.30 | -0.52 | -0.18 | |
Weighted-average shares used in net (loss) income per share calculation | ||||||
Weighted-average shares outstanding, basic and diluted (shares) | ||||||
780,701 | 720,753 | 543,185 | 403,619 | 110,597 | 99,857 | |
Loss per American Depositary Share ( ADS ) | ||||||
Net loss per American Depositary Share (“ADS”), basic and diluted (in dollars per share) | ||||||
-15.80 | -12.15 | -2.23 | -3.84 | -6.71 | - | |
Weighted-average ADSs outstanding, basic and diluted (shares) | ||||||
60,053 | 55,442 | 41,783 | 31,047 | - | - | |
Product [Member] | ||||||
Revenues | ||||||
222,596 | 130,885 | 24,428 | 0 | - | - | |
Collaboration revenue | ||||||
Revenues | ||||||
205,616 | 67,335 | 213,959 | 1,070 | 8,816 | 13,035 | |